Georgian Technology News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Georgian Technology News.

Press releases published on October 28, 2026

Oct. 28, 2026

Mitesco Appoints Senior Executive to the Board of Directors

Indeterminate GlobeNewswire

Oct. 28, 2026

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis

Indeterminate GlobeNewswire

Oct. 28, 2026

Humacyte Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent Covering Symvess and Other Bioengineered Tissues

Indeterminate GlobeNewswire

Oct. 28, 2026

ReversingLabs Launches Spectra Assure Catalog, Helping Organizations Securely Discover and Access Trusted Software

Indeterminate GlobeNewswire

Oct. 28, 2026

Newron Pharmaceuticals to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

Scipher Medicine Launches PrismTcell™, the Next Molecular Treatment Response Signature, for Abatacept in Rheumatoid Arthritis

Indeterminate GlobeNewswire

Oct. 28, 2026

EagleNXT Strengthens Global Sales Organization to Accelerate Growth and Capitalize on Dual-Use Market Opportunities

Indeterminate GlobeNewswire

Oct. 28, 2026

INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement

Indeterminate GlobeNewswire

Oct. 28, 2026

Minty Brings Its Free AI Shopping Companion to Android Ahead of the Holiday Season

Indeterminate GlobeNewswire

Oct. 28, 2026

Koah Builds Momentum as Advertisers Explore the Next Frontier of AI Advertising

Indeterminate GlobeNewswire

Oct. 28, 2026

UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer

Indeterminate GlobeNewswire

Oct. 28, 2026

ORYZON to participate in upcoming events in November

Indeterminate GlobeNewswire

Oct. 28, 2026

One Stop Systems Reports Q3 2026 Results

Indeterminate GlobeNewswire

Oct. 28, 2026

Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells

Indeterminate GlobeNewswire

Oct. 28, 2026

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 

Indeterminate GlobeNewswire

Oct. 28, 2026

Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

Oct. 28, 2026

Immutep Receives A$2.16 million French R&D Tax Incentive

Indeterminate GlobeNewswire

Oct. 28, 2026

Blue Lake Biotechnology Secures $5 Million Grant to Support Ongoing Pediatric Phase 1/2a Clinical Trial of Intranasal RSV Vaccine Candidate

Indeterminate GlobeNewswire

Oct. 28, 2026

PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections

Indeterminate GlobeNewswire

Oct. 28, 2026

Bilibili Inc. Announces Results of Extraordinary General Meeting

Indeterminate GlobeNewswire